Health in France

1,139 indicators covering health for France.

IndicatorLatest Year10-yr change Rank
Mean fasting blood glucose (mmol/l) 5.2 2009 down 1.9% 127th
Infant mortality rates 2 2024 up 17.6% 19th
Number of new leprosy cases with G2D among children 0 2024 β€” 35th
Most sold brand of cigarettes - price in currency reported 10 2020 up 78.6% 132nd
Most sold brand of cigarettes - taxes as a % of price - total tax 0.8% 2020 up 3.8% 8th
Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.5% 2020 down 6.9% 9th
Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 β€” 33rd
Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 β€” 41st
Most sold brand of cigarettes - taxes as a % of price - value added 0.2% 2020 up 6.2% 19th
Most sold brand of cigarettes - taxes as a % of price - specific 0.1% 2020 up 116.7% 113th
Most sold brand of cigarettes - price in US$ at official exchange 11.85 2020 up 62.3% 8th
Number healthy diet unaffordable 2.00 million 2024 up 66.7% 72nd
Import of environmentally sound technologies 38.40 billion 2020 up 2.4% 6th
Most sold brand of cigarettes - price in PPP$ 13.23 2020 up 101.1% 16th
Export of environmentally sound technologies 32.19 billion 2020 down 8.7% 7th
Pcv3 number unvaccinated 27,827 2023 down 67.0% 67th
Infant mortality 8,781 2010 up 125.2% 1st
Health risks - Regions β€” Respiratory system diseases mortality crude 68.8 Per 100 000 inhabitants 2023 up 20.2% 20th
Health risks - Regions β€” Circulatory system diseases mortality crude 199.4 Per 100 000 inhabitants 2023 down 7.8% 29th
Avoidable mortality 113,261 Deaths 2023 up 4.8% 9th
Avoidable mortality β€” Preventable mortality 77,757 Deaths 2023 up 4.5% 9th
Avoidable mortality β€” Treatable mortality 35,504 Deaths 2023 up 5.4% 13th
Reported number of human rabies deaths 1 2023 β€” 48th
Projected life expectancy by age (in completed years), sex and type 89.5 2100 up 0.9% 7th
Assumptions for mortality rates by age, sex and type of projection 0.0025 2100 down 15.7% 6th
Projected life expectancy by age, sex and type of projection 89.4 2100 up 1.4% 7th
Assumptions for mortality rates by age, sex and type of projection 0.0003 2100 down 34.6% 7th
Projected life expectancy by age (in completed years), sex and type 89.8 2100 up 1.1% 8th
Proportion of births delivered in a health facility (Facility births) 97.6% 2022 up 0.5% 58th
Life expectancy by age and sex 83 2024 up 0.7% 10th
Number of non-autochthonous leprosy cases 17 2024 up 112.5% 10th
Crude death rate hmd 9.42 2023 up 7.9% 25th
Births and deaths 9.42 2023 up 7.9% 25th
Period versus cohort life expectancy 82.88 2023 up 1.1% 10th
Annual death rate by age group 3.85 2023 up 6.6% 14th
Number reported cases of cholera 1 2015 down 50.0% 85th
HPV immunization coverage estimates among primary target cohort (9-14) 62.0% 2025 up 195.2% 76th
Life expectancy at birth oecd 82.4 2021 up 0.1% 12th
Risk factors for health β€” Tobacco consumption 12.8 Cigarettes per smoker per day 2024 down 5.2% 12th
How many health warnings are approved by the law for cigarette 15 2022 down 6.2% 11th
Tuberculosis - new and relapse cases 2,752 2010 down 55.0% 100th
Number of reported cholera deaths 0 2015 β€” 37th
Physiotherapists 104,229 2023 up 29.1% 4th
Health graduates 7,600 2024 up 41.7% 4th
Health personnel 270,874 2024 up 32.1% 3rd
Coverage of the human papillomavirus vaccine 45 2024 up 246.2% 58th
Generalist medical practitioners 95,095 2023 up 1.7% 5th
Percentage of principal display area mandated to be covered by health 65 2022 up 85.7% 25th
Average of 13 International Health Regulations core capacity scores 89.41 2017 up 41.9% 45th
New cases: pulmonary smear-negative 905 2011 down 38.6% 80th
Hospital beds by function and type of care 367,128 2024 down 10.6% 2nd
Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 26th
Percentage of principal display area mandated to be covered by health 65 2022 up 62.5% 30th
Total number of notified TB cases 4,845 2014 down 12.1% 81st
The number of people with susceptibility test result for rifampicin 17 2021 β€” 134th
Specialist medical practitioners 128,507 2023 up 17.1% 9th
Acute care β€” Acute myocardial infarction 30 day mortality 5.3 Per 100 admissions 2015 down 30.3% 15th
Acute care β€” Ischaemic stroke 30 day mortality 7.1 Per 100 admissions 2015 down 33.0% 13th
Acute care β€” Haemorrhagic stroke 30 day mortality 22.6 Per 100 admissions 2015 down 12.4% 11th
New cases: pulmonary smear unknown/not done 111 2011 down 72.4% 59th